Clinical Trial Update: Predicting Response to Capecitabine in Women With Metastatic Breast Cancer [NA]

View source ↗

Summary

A completed clinical trial update examining biomarkers to predict response to capecitabine in women with metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (Xeloda) (Capecitabine)

Snippet

Sponsor: Centre Antoine Lacassagne | Conditions: Breast Cancer | NA | Status: COMPLETED